Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Georgia

Peptide legality · Georgia · updated 2026-09-21

Are peptides legal in Georgia?

Gray area

Georgia permits peptide therapy under the federal framework, meaning FDA-approved peptides are legal by prescription while compounded peptides fall into a gray zone governed by FDA rules and Georgia Board of Pharmacy registration rather than a state-specific ban.

Legal status overview

Georgia permits peptide therapy under the federal framework and has not passed peptide-specific restrictions of its own. FDA-approved peptide medicines such as Wegovy® (semaglutide) are legal when prescribed by an authorized provider, and compounding is allowed through pharmacies registered with the Georgia Board of Pharmacy and inspected by the Georgia Drugs and Narcotics Agency. Compounded peptides are available only under limited conditions, and compounded medications are not FDA-approved, are not a generic, and have not been evaluated by the FDA. BPC-157 and similar research peptides remain in federal regulatory limbo following the April 2026 removal from FDA Category 2 without placement on the 503A bulk substances list. This is information, not medical or legal advice.

Key points

  • Georgia has no peptide-specific statute, so legality follows the federal FD&C Act framework enforced through the Georgia Board of Pharmacy and the Georgia Drugs and Narcotics Agency. [2]
  • FDA-approved peptide products including Wegovy® (semaglutide) are legal in Georgia when prescribed by an MD, DO, NP, or PA under applicable supervision or protocol agreements. [3]
  • Compounded semaglutide is permitted in Georgia only for documented clinical reasons after the FDA resolved the shortage, and compounded medications are not FDA-approved, not a generic, and not evaluated by the FDA. [6]
  • The 503A enforcement discretion window for compounded semaglutide copies ended April 22, 2025, and the 503B window ended May 22, 2025, closing the shortage pathway. [1]
  • Georgia med spas and clinics are advised to prescribe FDA-approved branded GLP-1s and to partner only with pharmacies properly registered with the Georgia Board of Pharmacy. [7]
  • BPC-157 came off FDA Category 2 effective April 23, 2026, but has not been added to the Section 503A Category 1 list, leaving its compounding status unresolved. [4]
  • A July 2026 FDA advisory committee vote recommended adding several peptides including BPC-157 to the 503A list, but the recommendation is non-binding. [5]
  • Georgia is not among the states that issued their own restrictive board guidance on compounded GLP-1s or peptides, so the federal floor governs practice in the state. [2]

Compound-by-compound status

BPC-157
Gray area
Removed from FDA Category 2 in April 2026 but not yet on the Section 503A bulk substances list; a July 2026 advisory vote to add it is non-binding, so lawful compounding remains uncertain.
GLP-1 class, for example Wegovy® (semaglutide) and Zepbound® (tirzepatide)
Gray area
FDA-approved brands are legal by prescription; compounded copies are restricted after the shortage resolution and allowed only for documented clinical need. Compounded versions are not FDA-approved, not a generic, and not evaluated by the FDA.
TB-500 (thymosin beta-4)
Gray area
Not FDA-approved and not on the 503A bulk substances list, so it sits in the same federal compounding limbo as other research peptides.
Growth hormone / somatropin
Restricted
FDA-approved by prescription, but federal law limits human growth hormone distribution to FDA-approved indications, making off-label supply restricted.

Frequently asked questions

Are peptides legal in Georgia?

Yes, within the federal framework. FDA-approved peptides are legal with a prescription, and compounding is allowed through pharmacies registered with the Georgia Board of Pharmacy, while research peptides depend on evolving FDA rules.

Can I still get compounded semaglutide in Georgia?

Only for a documented clinical reason after the FDA resolved the shortage. Compounded semaglutide is not FDA-approved, not a generic, and not evaluated by the FDA.

Is BPC-157 legal in Georgia?

BPC-157 is in a federal gray zone. It was removed from FDA Category 2 in April 2026 but is not yet on the 503A bulk substances list, so its compounding status is unsettled, including in Georgia.

Which pharmacies can compound peptides in Georgia?

Pharmacies must be registered with the Georgia Board of Pharmacy and are inspected by the Georgia Drugs and Narcotics Agency. Clinics are advised to partner only with properly registered pharmacies.

Does Georgia require an in-person exam before prescribing?

Guidance indicates the initial patient exam should be completed in person, subject to the prescriber's licensing rules and clinical judgment.

General information based on the sourced research above, not legal advice. For a specific situation in Georgia, consult a licensed attorney familiar with pharmaceutical law.